Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

NCT00324415 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NETWORK

Sponsor class

Conditions

Anal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
DRUG: fluorouracil
RADIATION: radiation therapy

Sponsor

AIDS Malignancy Consortium

Collaborators

[object Object]
[object Object]